 |
From: TSS (216-119-143-122.ipset23.wt.net)
Subject: Transmissible Spongiform Encephalopathies Advisory Committee
Date: September 17, 2004 at 7:19 pm PST
-------- Original Message --------
Subject: Transmissible Spongiform Encephalopathies Advisory Committee
Date: Fri, 17 Sep 2004 15:24:17 -0500
From: "Terry S. Singeltary Sr."
Reply-To: Bovine Spongiform Encephalopathy
To: BSE-L@UNI-KARLSRUHE.DETransmissible Spongiform Encephalopathies Advisory Committee horizontal rule
October 14, 2004 Meeting
Date and Time:
The meeting will be held on October 14, 2004, 8:00 a.m. to 5:30 p.m.
Location:
Hilton-Washington DC/Silver Spring, 8727 Colesville Road, Silver Spring,
MD, 20910, 301-589-5200
Contact Persons:
William Freas, Ph.D., or Sheila D. Langford, 301-827-0314, or FDA
Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the
Washington, DC area), code 3014512392. Please call the Information Line
for up-to-date information on this meeting.
Agenda:
On October 14, 2004, the Committee will hear updates on: USDA-licensed
tests for the diagnosis of bovine spongiform encephalopathy (BSE) and
other transmissible spongiform encephalopathies (TSE), review of the
worldwide BSE situation, new FDA/CFSAN BSE-food safety rules, and
labeling claims for TSE clearance studies for plasma derivative
products. The Committee will then discuss and make recommendations
regarding presumptive transfusion transmissions of variant Creutzfeldt
Jakob Disease (vCJD) and current FDA-recommended safeguards.
Oral Presentations:
Between approximately 9:20 and 9:50 a.m., and 2:45 and 3:15 p.m. on
October 14, 2004, oral presentations from the public will be scheduled.
Those desiring to make formal oral presentations should notify the
contact person before October 7, 2004. Updated September 16, 2004 http://www.fda.gov/cber/advisory/tse/tse1004.htm TSS
Follow Ups:
Post a Followup
|
